PATENT CLAIM ANALYSIS

Application Number: 15750068
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "230800"]

Abstract:
The present invention relates to liquid formulations of Fosaprepitant intended for parenteral administration. Further the invention also describes process for preparing such formulations.

Claim (Index 11):
The stable, liquid parenteral pharmaceutical formulation of  claim 10 , wherein the formulation comprises chelating agents selected from EDTA, DTPA, DOTA and salts thereof.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 88.0
- Lexical Diversity: 1.19048
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15342445', '15886247', '14242973', '15611785', '12434499']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7660083385736227
- 35 USC 102 Novelty (BERT): 0.5022519416048389
- Combined Prediction Score: 0.7396326988767443
- Mean Citation Score: 202.820424
- Max Citation Score: 253.53969
- Similarity Product: 187.6185569622123

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test